Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-31 @ 9:49 PM
Study NCT ID:
NCT02558894
Status:
COMPLETED
Last Update Posted:
2018-08-02
First Post:
2015-08-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-15
Completion Date Type:
ACTUAL
First Submit Date:
2015-08-27
First Submit QC Date:
None
Study First Post Date:
2015-09-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-05-28
Results First Submit QC Date:
None
Results First Post Date:
2018-08-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-09
Last Update Post Date:
2018-08-02
Last Update Post Date Type:
ACTUAL